FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mats Ehinger

Research Profile

Living Beings

Physiology

Anatomy

Hematopoietic Stem Cells

Disorders

Procedures

Chemicals & Drugs

Genes & Molecular Sequences

Genes, p53

Co-author Network

Publications

TOP 3
Catarina Lundin; Mikael Behrendtz; Andrea Biloglav; Mats Ehinger; Lars Hjorth; Bertil Johansson
Submicroscopic genomic imbalances in Burkitt lymphomas/leukemias: association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis.
N Hansen; J Ishiko; Marcus Järås; P Johnels; N Landberg; Henrik Lilljebjörn; J V Melo; M Rissler; M Wahlestedt; H Ågerstam; W S Alexander; M Askmyr; David Bryder; Mats Ehinger; Thoas Fioretos
SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.
K Siva; Kenichi Miharada; E Rörby; Mats Ehinger; P Jaako; G Karlsson; Stefan Karlsson
SPARC is dispensable for murine hematopoiesis, despite its suspected pathophysiological role in 5q-myelodysplastic syndrome.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mats Ehinger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Catarina Lundin; Mikael Behrendtz; Andrea Biloglav; Mats Ehinger; Lars Hjorth; Bertil Johansson
Submicroscopic genomic imbalances in Burkitt lymphomas/leukemias: association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis.
Genes, chromosomes & cancer 2013;52(4):370-7.
2013: N Hansen; J Ishiko; Marcus Järås; P Johnels; N Landberg; Henrik Lilljebjörn; J V Melo; M Rissler; M Wahlestedt; H Ågerstam; W S Alexander; M Askmyr; David Bryder; Mats Ehinger; Thoas Fioretos
SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.
Leukemia 2013;27(1):130-5.
2012: K Siva; Kenichi Miharada; E Rörby; Mats Ehinger; P Jaako; G Karlsson; Stefan Karlsson
SPARC is dispensable for murine hematopoiesis, despite its suspected pathophysiological role in 5q-myelodysplastic syndrome.
Leukemia 2012;26(11):2416-9.
2012: Karin Rydström; Eva Cavallin-Ståhl; Patrik Edén; Mats Ehinger; Mats Jerkeman; Patrick Joost; Johan Linderoth
Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma.
Leukemia & lymphoma 2012;53(9):1764-8.
2012: Christian H Geisler; Mats Jerkeman; Marja-Liisa Karjalainen-Lindsberg; Eva Kimby; Arne Kolstad; Outi Kuittinen; Anna Laurell; Grete Fossum Lauritzsen; Herman Nilsson-Ehle; Marie Nordström; Lone B Pedersen; Elisabeth Ralfkiaer; Riikka Räty; Christer Sundström; Niels S Andersen; Hans Bentzen; Peter Brown; Jan Delabie; Mats Ehinger; Erkki Elonen; Mikael Eriksson
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.
British journal of haematology 2012;158(3):355-62.
2011: Pekka Jaako; Christopher Baum; David Bryder; Mats Ehinger; Steven Ellis; Johan Flygare; Adrianna Henson; Jonas Larsson; Karin Olsson; Ronan Quere; Johan Richter; Axel Schambach; Stefan Karlsson
Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia.
Blood 2011;118(23):6087-96.
2011: Ariane Tormin; Ou Li; Jan Claas Brune; Stuart Walsh; Birgit Schütz; Mats Ehinger; Nicholas Ditzel; Moustapha Kassem; Stefan Scheding
CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization.
Blood 2011;117(19):5067-77.
2010: Karin Rydström; Johan Linderoth; Heidi Nyman; Mats Ehinger; Patrick Joost; Pär-Ola Bendahl; Sirpa Leppä; Mats Jerkeman
CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Leukemia & lymphoma 2010;51(9):1643-8.
2010: Carmen Flores; Teun J de Vries; Ilana Moscatelli; Maria Askmyr; Ton Schoenmaker; Geerling E J Langenbach; Mats Ehinger; Vincent Everts; Johan Richter
Nonablative neonatal bone marrow transplantation rapidly reverses severe murine osteopetrosis despite low-level engraftment and lack of selective expansion of the osteoclastic lineage.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2010;25(9):2069-77.
2010: Sofie Singbrant; Göran Karlsson; Mats Ehinger; Karin Olsson; Pekka Jaako; Ken-Ichi Miharada; Matthias Stadtfeld; Thomas Graf; Stefan Karlsson
Canonical BMP signaling is dispensable for hematopoietic stem cell function in both adult and fetal liver hematopoiesis, but essential to preserve colon architecture.
Blood 2010;115(23):4689-98.
2009: Ida Berglin Enquist; Eva Nilsson; Jan-Eric Månsson; Mats Ehinger; Johan Richter; Stefan Karlsson
Successful low-risk hematopoietic cell therapy in a mouse model of type 1 Gaucher disease.
Stem cells (Dayton, Ohio) 2009;27(3):744-52.
2009: Maria Askmyr; Johan Holmberg; Carmen Flores; Mats Ehinger; Tord Hjalt; Johan Richter
Low-dose busulphan conditioning and neonatal stem cell transplantation preserves vision and restores hematopoiesis in severe murine osteopetrosis.
Experimental hematology 2009;37(2):302-8.
2008: Johan Linderoth; Patrik Edén; Mats Ehinger; Jeanette Valcich; Mats Jerkeman; Pär-Ola Bendahl; Mattias Berglund; Gunilla Enblad; Martin Erlanson; Göran Roos; Eva Cavallin-Ståhl
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
British journal of haematology 2008;141(4):423-32.
2008: Mats Ehinger; Johan Linderoth; Birger Christensson; Birgitta Sander; Eva Cavallin-Ståhl
A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus.
American journal of clinical pathology 2008;129(4):630-8.
2007: Ida Berglin Enquist; Christophe Lo Bianco; Andreas Ooka; Eva Nilsson; Jan-Eric Månsson; Mats Ehinger; Johan Richter; Roscoe O Brady; Deniz Kirik; Stefan Karlsson
Murine models of acute neuronopathic Gaucher disease.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(44):17483-8.
2007: Johan Linderoth; Mats Ehinger; Mats Jerkeman; Pär-Ola Bendahl; Måns Akerman; Mattias Berglund; Gunilla Enblad; Martin Erlanson; Göran Roos; Eva Cavallin-Ståhl
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.
Leukemia & lymphoma 2007;48(9):1774-9.
2007: Johan Linderoth; Mats Ehinger; Måns Akerman; Eva Cavallin-Ståhl; Gunilla Enblad; Martin Erlanson; Mats Jerkeman
Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma.
European journal of haematology 2007;79(2):146-9.
2007: Maria K Johansson; Teun J de Vries; Ton Schoenmaker; Mats Ehinger; Ann C M Brun; Anders Fasth; Stefan Karlsson; Vincent Everts; Johan Richter
Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice.
Blood 2007;109(12):5178-85.
2007: Mattias Magnusson; Ann C M Brun; Noriko Miyake; Jonas Larsson; Mats Ehinger; Jon Mar Bjornsson; Anton Wutz; Mikael Sigvardsson; Stefan Karlsson
HOXA10 is a critical regulator for hematopoietic stem cells and erythroid/megakaryocyte development.
Blood 2007;109(9):3687-96.
2007: Göran Karlsson; Ulrika Blank; Jennifer L Moody; Mats Ehinger; Sofie Singbrant; Chu-Xia Deng; Stefan Karlsson
Smad4 is critical for self-renewal of hematopoietic stem cells.
The Journal of experimental medicine 2007;204(3):467-74.
2006: Ida Berglin Enquist; Eva Nilsson; Andreas Ooka; Jan-Eric Månsson; Karin Olsson; Mats Ehinger; Roscoe O Brady; Johan Richter; Stefan Karlsson
Effective cell and gene therapy in a murine model of Gaucher disease.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(37):13819-24.
2006: Maria Johansson; Lina Jansson; Mats Ehinger; Anders Fasth; Stefan Karlsson; Johan Richter
Neonatal hematopoietic stem cell transplantation cures oc/oc mice from osteopetrosis.
Experimental hematology 2006;34(2):242-9.
2005: Erik Björck; Sara Ek; Ola Landgren; Mats Jerkeman; Mats Ehinger; Magnus Björkholm; Carl A K Borrebaeck; Anna Porwit-MacDonald; Magnus Nordenskjöld
High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma.
Blood 2005;105(7):2908-15.
2004: Ann C M Brun; Jon Mar Björnsson; Mattias Magnusson; Nina Larsson; Per Leveén; Mats Ehinger; Eva Nilsson; Stefan Karlsson
Hoxb4-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells.
Blood 2004;103(11):4126-33.
2003: Jonas Larsson; Ulrika Blank; Hildur Helgadottir; Jon Mar Björnsson; Mats Ehinger; Marie-José Goumans; Xiaolong Fan; Per Levéen; Stefan Karlsson
TGF-beta signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro.
Blood 2003;102(9):3129-35.
2003: Jon Mar Björnsson; Nina Larsson; Ann C M Brun; Mattias Magnusson; Elisabet Andersson; Patrik Lundström; Jonas Larsson; Ewa Repetowska; Mats Ehinger; R Keith Humphries; Stefan Karlsson
Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4.
Molecular and cellular biology 2003;23(11):3872-83.
2003: Sarah H Walsh; Mia Thorsélius; Anna Johnson; Ola Söderberg; Mats Jerkeman; Erik Björck; Inger Eriksson; Ulf Thunberg; Ola Landgren; Mats Ehinger; Eva Löfvenberg; Kristina Wallman; Gunilla Enblad; Birgitta Sander; Anna Porwit-MacDonald; Michael Dictor; Tor Olofsson; Christer Sundström; Göran Roos; Richard Rosenquist
Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma.
Blood 2003;101(10):4047-54.
2002: Sara Ek; Carl-Magnus Högerkorp; Michael Dictor; Mats Ehinger; Carl A K Borrebaeck
Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells.
Cancer research 2002;62(15):4398-405.
2002: Per Levéen; Jonas Larsson; Mats Ehinger; Corrado M Cilio; Martin Sundler; Lottie Jansson Sjöstrand; Rikard Holmdahl; Stefan Karlsson
Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable.
Blood 2002;100(2):560-8.
2000: K Chylicki; Mats Ehinger; H Svedberg; Urban Gullberg
Characterization of the molecular mechanisms for p53-mediated differentiation.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 2000;11(11):561-71.
2000: K Chylicki; Mats Ehinger; H Svedberg; G Bergh; Inge Olsson; Urban Gullberg
p53-mediated differentiation of the erythroleukemia cell line K562.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 2000;11(6):315-24.
2000: Eva Ceballos; M Dolores Delgado; P Gutierrez; Carlos Richard; D Müller; Martin Eilers; Mats Ehinger; Urban Gullberg; Javier León
c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells.
Oncogene 2000;19(18):2194-204.
1999: G Bergh; Mats Ehinger; Inge Olsson; S E Jacobsen; Urban Gullberg
Involvement of the retinoblastoma protein in monocytic and neutrophilic lineage commitment of human bone marrow progenitor cells.
Blood 1999;94(6):1971-8.
1999: Michael Dictor; Mats Ehinger; Fredrik Mertens; Jan Akervall; Johan Wennerberg
Abnormal cell cycle regulation in malignancy.
American journal of clinical pathology 1999;112(1 Suppl 1):S40-52.
1998: Mats Ehinger; G Bergh; Ellinor Johnsson; Bo Baldetorp; Inge Olsson; Urban Gullberg
p53-dependent and -independent differentiation of leukemic U-937 cells: relationship to cell cycle control.
Experimental hematology 1998;26(11):1043-52.
1997: Mats Ehinger; G Bergh; Ellinor Johnsson; Urban Gullberg; Inge Olsson
The tumor suppressor gene p53 can mediate transforming growth [corrected] factor beta1-induced differentiation of leukemic cells independently of activation of the retinoblastoma protein.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997;8(10):1127-37.
1997: G Bergh; Mats Ehinger; Tor Olofsson; Bo Baldetorp; Ellinor Johnsson; H Brycke; G Lindgren; Inge Olsson; Urban Gullberg
Altered expression of the retinoblastoma tumor-suppressor gene in leukemic cell lines inhibits induction of differentiation but not G1-accumulation.
Blood 1997;89(8):2938-50.
1996: Inge Olsson; G Bergh; Mats Ehinger; Urban Gullberg
Cell differentiation in acute myeloid leukemia.
European journal of haematology 1996;57(1):1-16.
1996: Mats Ehinger; G Bergh; Tor Olofsson; Bo Baldetorp; Inge Olsson; Urban Gullberg
Expression of the p53 tumor suppressor gene induces differentiation and promotes induction of differentiation by 1,25-dihydroxycholecalciferol in leukemic U-937 cells.
Blood 1996;87(3):1064-74.
1995: Inge Olsson; G Bergh; Mats Ehinger; Urban Gullberg
[Hematopoiesis. Biological mass production closely regulated by cytokines].
Läkartidningen 1995;92(14):1468-70, 1475-6.
1995: Urban Gullberg; G Bergh; Mats Ehinger; Inge Olsson
Receptors for hematopoietic regulatory cytokines: overview of structure and function.
Cancer treatment and research 1995;80():1-24.
1995: Mats Ehinger; E Nilsson; A M Persson; Inge Olsson; Urban Gullberg
Involvement of the tumor suppressor gene p53 in tumor necrosis factor-induced differentiation of the leukemic cell line K562.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1995;6(1):9-17.